OLPX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP announces that…

OLPX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP announces that…

Facebook
Twitter
LinkedIn

SAN DIEGO, Dec. 10, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that buyers or acquirers of Olaplex Holdings, Inc. OLPX Common stock pursuant to and/or traceable to Olaplex’s initial public offering (the “IPO”) conducted on or about September 30, 2021 will have until January 17, 2023 to file for appointment as Lead Plaintiff. Titled Lilies v Olaplex Holdings, Inc.No. 22-cv-08395 (CD Cal.), the Olaplex Class action lawsuit charges Olaplex and some of its top officers and directors with violations of the Securities Act of 1933.

If you have suffered significant losses and are the main plaintiff in the Olaplex Class action, please provide your information here:

https://www.rgrdlaw.com/cases-olaplex-holdings-inc-class-action-lawsuit-olpx.html

You can also contact a lawyer JC Sanchez of Robbins Geller by phone at 800/449-4900 or email jsanchez@rgrdlaw.com.

CASE CLAIMS: Olaplex manufactures and sells hair care products. Subsequent to its IPO, Olaplex issued more than 73 million shares of its common stock to the public at a price of $21.00 per share, generating approximate proceeds for Olaplex in excess of $1.4 billion.

Olaplex claims to participate in the “prestige segment” of the hair care market, which Olaplex claims is “expected to be the fastest growing segment of the global hair care market from 2020 to 2025.” But as the Olaplex The class action alleges that the IPO’s offering documents made false and/or misleading statements and/or failed to disclose that: (i) macroeconomic pressures and competition in the hair care market were more resilient than Olaplex had portrayed to investors; (ii) accordingly, Olaplex was unlikely to maintain its sales and earnings momentum; and (iii) as a result, it was unlikely that Olaplex would be able to achieve the financial and operational growth projected in the IPO offering documents.

On September 29, 2022, an analyst for Piper Sandler downgraded Olaplex from…

[ad_2]

Source story

More to explorer